Fig. 2
From: 4D label-free proteomics analysis of oxygen-induced retinopathy with or without anti-VEGF treatment
Comparisons of the heatmaps of the differential proteins expressed in three groups. A Comparisons of the heatmaps of the differential proteins expressed between the ranibizumab group and the OIR group. B Comparisons of the heatmaps of the differential proteins expressed between the OIR group and the normal group. C Comparisons of the heatmaps of the differential proteins expressed between the ranibizumab group and the normal group. Higher red and blue intensities indicate higher degrees of upregulation and downregulation, respectively